Study Name: Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
13 locations found
- GSK Investigational Site
Location: Birmingham, Alabama 35294
- GSK Investigational Site
Location: Duarte, California 91010
- GSK Investigational Site
Location: Los Angeles, California 90095
- GSK Investigational Site
Location: San Francisco, California 94143
- GSK Investigational Site
Location: Chicago, Illinois 60611
- GSK Investigational Site
Location: Lake Success, New York 11042
- GSK Investigational Site
Location: New York, New York 10032
- GSK Investigational Site
Location: Winston-Salem, North Carolina 27157
- GSK Investigational Site
Location: Portland, Oregon 97239
- GSK Investigational Site
Location: Philadelphia, Pennsylvania 19141
- GSK Investigational Site
Location: Pittsburgh, Pennsylvania 15232
- GSK Investigational Site
Location: Houston, Texas 77030
- GSK Investigational Site
Location: Seattle, Washington 98109
|